Gastrointestinal Pathology – Masters of Pathology Series (CME Videos)

• Anal Pathology, Nonneoplastic and Key Neoplasms – Elizabeth Montgomery, MD
• Barrett’s Esophagus and Neoplasms of the Esophagus – What’s Hot and What’s Not – Elizabeth Montgomery, MD
• Colorectal Neoplasms 1 – Elizabeth Montgomery, MD
• Colorectal Neoplasms 2 – Elizabeth Montgomery, MD
• Gastric Neoplasms, Including HER2 Testing – Elizabeth Montgomery, MD
• Highlights of Appendix Pathology – Elizabeth Montgomery, MD
• Latrogenic Injury to the Gastrointestinal Tract – Elizabeth Montgomery, MD
• Mesenchymal Tumors of the Gastrointestinal Tract, Part 1 – Elizabeth Montgomery, MD
• Mesenchymal Tumors of the Gastrointestinal Tract, Part 2 – Elizabeth Montgomery, MD
• Nonneoplastic Colorectal Pathology – Elizabeth Montgomery, MD
• Nonneoplastic Esophageal Pathology – Elizabeth Montgomery, MD
• Nonneoplastic Gastric Pathology – The Company the Neoplasms Keep – Elizabeth Montgomery, MD
• Polyposis Syndromes Affecting the Gastrointestinal Tract – Elizabeth Montgomery, MD
• Small Intestinal Neoplasms – Elizabeth Montgomery, MD
• Small Intestinal Nonneoplastic Pathology – Elizabeth Montgomery, MD

Accreditation Statement

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Date of Original Release: July 31, 2015

Learning Objectives

After viewing this program, the participant will be better able to:

• Discuss the most recent histopathological classifications of various gastrointestinal polyps and neoplasms currently recognized by the WHO in all areas of the gastrointestinal tract, including mesenchymal tumors.
• Recognize multiple forms of nonneoplastic injury to the gastrointestinal tract, including iatrogenic injury, disorders of malabsorption, inflammatory bowel disease, and infectious conditions including sexually transmitted disease-associated injury to the anorectal area.
• Decide what immunoreactions are most appropriate for validating the diagnosis of the main gastrointestinal tumors.
• Describe the main molecular genetic alterations, which occur in key gastrointestinal tumors, and how that knowledge would help to determine future target therapies.